Diabetes is a chronic disease that demands lifelong management. It impacts all age groups – babies, children, young and older adults - and if not managed properly, there can be devastating consequences. Lack of access to insulin for people with type 1 diabetes is fatal.
MSF treats people living with diabetes in Lebanon, Sudan, Kenya and South Africa. In Lebanon, we offer insulin pens for all patients to inject their insulin. The pens offer a wide range of benefits over more traditional insulin delivery options for patients, their families and caregivers.
On World Diabetes Day, we share the stories of three people living with diabetes, whom our medical team in the town of Arsal in northern Lebanon are supporting. We hope by hearing the voices of patients, we can make the case more forcefully for people with diabetes everywhere to have access to insulin pens wherever they live and at an affordable price.
Read more about three young people living with diabetes in Arsal, in their own words. And find out more generally about our work to improve access to insulin.
Infographics: The benefits of insulin pens for people living with diabetes
